[1]
R. Zahid and S. Riaz, “Systematic Review of the SARS-CoV-2 Viral Vector Vaccine AstraZeneca (Azd1222)”, BioSci Rev., vol. 4, no. 2, pp. 1-20, Jun. 2022.